Register for our free email digests:
Division of Jazz Pharmaceuticals PLC
Latest From Ironshore Pharmaceuticals & Development Inc.
Biscayne and Japanese CRO SNBL create spin-outs to advance programs; liver disease specialist Ascletis gains funds as it shifts away from HCV; Neon gets $100m to put into its cancer vaccines; and other highlights of recent VC funding.
- Antisense, Oligonucleotides
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Large Molecule
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Hepatic (Liver)
- Pharma Research SRL
- Western Europe
- Parent & Subsidiaries
- Jazz Pharmaceuticals PLC
- Senior Management
Finton Keegan, Chmn. & CEO
Salvatore Calabrese, SVP, Fin., CFO & COO
Adrian Haigh, SVP, Commercial Operations
Giorgio Mosconi, MD, PhD, SVP & Scientific Dir.
- Contact Info
Phone: (39) 031-5373 200
Piazza XX Settembre, 2
Villa Guardia, 22079
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.